Skip to main content
. 2019 Oct 31;10:1164. doi: 10.3389/fneur.2019.01164

Table 3.

Multivariate analyses of predicting hematoma expansion in the original cohort.

Crude OR (95%CI) P-value Adjusteda OR (95%CI) P-value
>6 mL growth (N = 200)
WBC count 0.96 (0.92–1.01) 0.088 0.94 (0.90–0.99) 0.021
Neutrophil count 0.94 (0.90–0.99) 0.008 0.93 (0.89–0.98) 0.008
Monocyte count 1.74 (1.10–2.78) 0.019 1.45 (0.89–2.35) 0.131
Lymphocyte count 1.27 (1.09–1.49) 0.003 1.09 (0.90–1.31) 0.385
Eosinophil count 7.11 (2.30–21.97) 0.001 3.64 (1.04–12.7) 0.043
>12.5 mL growth (N = 116)
WBC count 0.97 (0.92–1.02) 0.234 0.98 (0.92–1.04) 0.495
Neutrophil count 0.94 (0.89–0.99) 0.023 0.96 (0.91–1.02) 0.229
Monocyte count 2.09 (1.26–3.48) 0.004 1.98 (1.19–3.30) 0.009
Lymphocyte count 1.35 (1.13–1.61) 0.001 1.14 (0.92–1.40) 0.233
Eosinophil count 11.39 (3.27–39.66) <0.001 5.03 (1.13–22.3) 0.034
>33% growth (N = 174)
WBC count 0.92 (0.88–0.97) 0.001 0.94 (0.89–0.99) 0.02
Neutrophil count 0.89 (0.85–0.94) <0.001 0.96 (0.87–0.97) 0.003
Monocyte count 1.79 (1.12–2.88) 0.016 1.62 (0.99–2.64) 0.056
Lymphocyte count 1.42 (1.21–1.67) <0.001 1.18 (0.99–1.42) 0.072
Eosinophil count 19.12 (5.81–62.94) <0.001 6.71 (1.73–25.9) 0.006
>6 mL or 33% growth (N = 225)
WBC count 0.95 (0.91–0.99) 0.008 0.93 (0.89–0.98) 0.004
Neutrophil count 0.92 (0.88–0.96) <0.001 0.92 (0.87–0.96) <0.001
Monocyte count 1.73 (1.09–2.75) 0.019 1.44 (0.90–2.30) 0.127
Lymphocyte count 1.37 (1.17–1.59) <0.001 1.19 (0.99–1.42) 0.053
Eosinophil count 10.38 (3.37–32.02) <0.001 4.66 (1.28–17.02) 0.02
>12.5 mL or 33% growth (N = 182)
WBC count 0.93 (0.89–0.98) 0.004 0.95 (0.90–0.99) 0.034
Neutrophil count 0.90 (0.86–0.95) <0.001 0.93 (0.88–0.98) 0.005
Monocyte count 1.80 (1.12–2.89) 0.015 1.61 (0.92–2.61) 0.124
Lymphocyte count 1.41 (1.20–1.66) <0.001 1.20 (0.92–1.43) 0.112
Eosinophil count 17.07 (5.25–55.49) <0.001 6.51 (1.71–24.82) 0.006

OR for 103 cells increase. N represents the number of positive hematoma expansion.

a

Adjusted by sex, hypertension, history of cerebral hemorrhage, glasgow coma scale score, time from symptom onset to initial CT, and baseline hematoma volume. WBC, white blood cell; OR, odds ratio; CI, confidence interval; CT, computed tomography.